The Cardiovascular Research Foundation is partnering with VEITHsymposium, one of the largest annual meetings in vascular medicine, to enhance conference material at both VEITHsymposium and the CRF’s yearly Transcatheter Cardiovascular Therapeutics conference, the groups announced June 20.
The relationship between CRF and VEITHsymposium will be a symbiotic one, according to a combined statement—VEITHsymposium leadership will be “actively involved” in developing the endovascular program for TCT 2019, while CRF will develop a two-day hands-on training pavilion and interventional sessions at this year’s VEITHsymposium. VEITHsymposium is also expected to plan dedicated critical limb ischemia and aortic sessions for TCT, which is slated for Sept. 25-29 in San Francisco.
“This alliance between two leading continuing medical educational meetings has at its goal the provision of the best, most up-to-date information possible to all those specializing in the care of non-cardiac vascular disease patients,” Frank J. Veith, chairman of VEITHsymposium, said. “This unique alliance will lead to better, more appropriate care for the increasing number of vascular disease patients around the world, while recognizing the reality that many specialties are involved in providing this care.”
Juan F. Granada, MD, president and CEO of CRF, said the foundation was happy to join forces with “such an esteemed educational conference” as VEITHsymposium, which will take place Nov. 19-23 in New York City.
“Over the last 45 years they have had a remarkable influence on medical education and innovation in the field, which has had a tremendous impact on patient care,” he said.